[Skip to Content]
[Skip to Content Landing]
Citations 0
Health Agencies Update
July 22 2009

H1N1 Vaccine

JAMA. 2009;302(4):375. doi:10.1001/jama.2009.1047

Several companies are developing a vaccine for novel influenza A H1N1 virus, and clinical trials of the vaccine are expected to begin soon, according to the national Centers for Disease Control and Prevention (CDC).

At a press briefing June 11, Anne Schuchat, MD, interim deputy director for the CDC's Science and Public Health Program, said that the US government has launched an effort to develop a vaccine against this currently circulating strain, and that the vaccine was expected to be available this fall. In fact, Novartis AG, GlaxoSmithKline PLC, and Baxter International have all announced they have begun the process.

First Page Preview View Large
First page PDF preview
First page PDF preview
×